Colgate-Palmolive’s premium strategy and pet nutrition expansion drive growth, with a $115 target signaling 26% upside. Read more about CL stock here.
The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 7.34%% during the fourth quarter of 2024. Click here to read the full commentary.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback